说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 句库 -> 重组人甲状旁腺激素(1-84)
1.
Quality research of the recombinant human parathyroid hormone(1-84)
重组人甲状旁腺激素(1-84)的质量研究
2.
Influence of Recombinant Human Parathyroid Hormone and Estrogen on Bone Metabolism and IGF-1 System in Ovariectomized Rats.;
人重组甲状旁腺素和雌激素对去卵巢大鼠骨代谢和胰岛素样生长因子-1系统的影响
3.
Phase Ⅰ Clinical Trial of Recombinant Human Parathyroid Hormone(1-34) in Healthy Volunteers;
注射用重组人甲状旁腺素(1-34)的Ⅰ期临床试验研究
4.
Studies on Expression and Purification of Recombinant Human Parathyroid Hormone 1-34 in Pichia Pastoris
重组人甲状旁腺素1-34在毕赤酵母表达及纯化的研究
5.
Topical Administration of Recombinant Human Parathyroid Hormone (1-34) on Psoriasis-like Mouse Model
重组人甲状旁腺素(1-34)对银屑病样小鼠模型的影响
6.
Effect of Recombinant Human Parathormone(1-34) on the Excretion of IL-6 and IL-8 by Keratinocyte
重组人甲状旁腺素(1-34)对角质形成细胞分泌IL-6和IL-8的影响
7.
Pharmacokinetics study of recombinant human parathyroid hormone in Chinese healthy volunteers
重组人甲状旁腺激素在中国健康人体内的药动学
8.
Protective Effect of PTH Against Hematopoietic Damage in Mice;
人重组甲状旁腺素促进小鼠造血功能的恢复
9.
The Expression of Human Parathyroid Hormone in E.coli;
人甲状旁腺激素在大肠杆菌中的表达
10.
THE CONSTRUCTION OF THE PLASMID VECTOR OF HUMAN PARATHYROID HORMONE GENE;
人甲状旁腺激素基因表达载体的构建
11.
The Effect of Human Parathyroid Hormone 1-34 on the Development and Mineralization of Dentin;
人甲状旁腺激素1-34对牙本质形成和矿化影响的实验研究
12.
parathyroid gland
ph.1. 【解】甲状旁腺
13.
Cloning and Expression of DNA Sequences Encoding PTH-related Peptides (1-141 and 1-86);
甲状旁腺激素相关肽(1-141和1-86)编码序列的克隆与表达
14.
The Correlation between Castrate Osteoporosis and Femur Parathyroid Hormone Receptor 1 in Rats
染料木素对去势大鼠骨质疏松和甲状旁腺激素受体1的作用研究
15.
Construction and Expression of Recombinant Fusion Protein hPTH(1-34)a'a-HSA
人甲状旁腺激素(1-34)二联体与人血清白蛋白融合蛋白的构建及表达
16.
Parathyroid Hormone (1-34) for the Treatment of Postmenopausal Osteoporosis: A Systematic Review
甲状旁腺激素(1-34)治疗绝经后骨质疏松症疗效的系统评价
17.
The Correlation between castrate osteoporosis and femur parath yroid hormone receptor 1 in rats
去势大鼠骨质疏松与股骨甲状旁腺激素受体1相关性研究
18.
Martin-Albright syndrome
假性甲状旁腺激素反应性减退